Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (09.02.2026)
HOCH Abgang Schlüsselpersonen (09.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 09.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n Form 8-K is incorporated by reference into this Item 5.02. In accordance with the terms of the Merger Agreement, (i) e |
| 22.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 29.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ult of, or that are associated with, the RIF. Item 5.02 Departure of Directors or Certain Officers; Election of Direct |
Stammdaten
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Generation Bio Co. |
|---|---|
| Ticker | GBIO |
| CIK | 0001733294 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 36,0 Mio. USD |
| Beta | 2,01 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | 1,594,000 | -5,520,000 | -0.82 | 121,896,000 | 50,560,000 |
| 2025-06-30 | 10-Q | 765,000 | -20,923,000 | -3.12 | 179,432,000 | 54,101,000 |
| 2025-03-31 | 10-Q | 8,723,000 | -14,802,000 | -0.22 | 201,348,000 | 73,332,000 |
| 2024-12-31 | 10-K | 19,892,000 | -131,668,000 | -1.98 | 231,197,000 | 86,204,000 |
| 2024-09-30 | 10-Q | 7,554,000 | -15,313,000 | -2.29 | 248,784,000 | 104,442,000 |
| 2024-06-30 | 10-Q | 4,091,000 | -20,432,000 | -3.07 | 265,264,000 | 115,407,000 |
| 2024-03-31 | 10-Q | 4,059,000 | -74,541,000 | -1.12 | 285,879,000 | 131,991,000 |
| 2023-12-31 | 10-K | 5,904,000 | -126,612,000 | -1.96 | 374,758,000 | 203,128,000 |
| 2023-09-30 | 10-Q | 2,146,000 | -28,266,000 | -0.43 | 381,492,000 | 231,914,000 |
| 2023-06-30 | 10-Q | 880,000 | -31,066,000 | -0.47 | 404,883,000 | 254,287,000 |
| 2023-03-31 | 10-Q | 0 | -32,094,000 | -0.53 | 431,417,000 | 279,139,000 |
| 2022-12-31 | 10-K | 0 | -136,639,000 | -2.35 | 376,264,000 | 282,493,000 |
| 2022-09-30 | 10-Q | 0 | -31,306,000 | -0.53 | 402,799,000 | 308,749,000 |
| 2022-06-30 | 10-Q | 0 | -37,929,000 | -0.66 | 418,994,000 | 324,874,000 |
| 2022-03-31 | 10-Q | -34,999,000 | -0.61 | 444,026,000 | 352,915,000 | |
| 2021-12-31 | 10-K | 0 | -119,151,000 | -2.12 | 476,771,000 | 381,746,000 |
| 2021-09-30 | 10-Q | -31,855,000 | -0.56 | 464,033,000 | 407,210,000 | |
| 2021-06-30 | 10-Q | -30,791,000 | -0.55 | 490,792,000 | 433,402,000 | |
| 2021-03-31 | 10-Q | -25,562,000 | -0.46 | 514,081,000 | 458,736,000 | |
| 2020-12-31 | 10-K | -24,226,000 | -2.95 | 294,155,000 | 268,013,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.